|
Liu, A x; Du, W; Liu, J P et al. (2000) RhoB alteration is necessary for apoptotic and antineoplastic responses to farnesyltransferase inhibitors. Mol Cell Biol 20:6105-13
|
|
Du, W; Lebowitz, P F; Prendergast, G C (1999) Elevation of alpha2(I) collagen, a suppressor of Ras transformation, is required for stable phenotypic reversion by farnesyltransferase inhibitors. Cancer Res 59:2059-63
|
|
Du, W; Liu, A; Prendergast, G C (1999) Activation of the PI3'K-AKT pathway masks the proapoptotic effects of farnesyltransferase inhibitors. Cancer Res 59:4208-12
|
|
Du, W; Lebowitz, P F; Prendergast, G C (1999) Cell growth inhibition by farnesyltransferase inhibitors is mediated by gain of geranylgeranylated RhoB. Mol Cell Biol 19:1831-40
|
|
Du, W; Prendergast, G C (1999) Geranylgeranylated RhoB mediates suppression of human tumor cell growth by farnesyltransferase inhibitors. Cancer Res 59:5492-6
|
|
Basu, A; Rodeck, U; Prendergast, G C et al. (1999) Loss of insulin-like growth factor I receptor-dependent expression of p107 and cyclin A in cells that lack the extracellular matrix protein secreted protein acidic and rich in cysteine. Cell Growth Differ 10:721-8
|
|
Lebowitz, P F; Prendergast, G C (1998) Functional interaction between RhoB and the transcription factor DB1. Cell Adhes Commun 6:277-87
|
|
Lebowitz, P F; Casey, P J; Prendergast, G C et al. (1997) Farnesyltransferase inhibitors alter the prenylation and growth-stimulating function of RhoB. J Biol Chem 272:15591-4
|
|
Lebowitz, P F; Du, W; Prendergast, G C (1997) Prenylation of RhoB is required for its cell transforming function but not its ability to activate serum response element-dependent transcription. J Biol Chem 272:16093-5
|
|
Lebowitz, P F; Sakamuro, D; Prendergast, G C (1997) Farnesyl transferase inhibitors induce apoptosis of Ras-transformed cells denied substratum attachment. Cancer Res 57:708-13
|
Showing the most recent 10 out of 12 publications
